Welcome to our dedicated page for CME Group news (Ticker: CME), a resource for investors and traders seeking the latest updates and insights on CME Group stock.
CME Group Inc. operates a derivatives marketplace that supports trading and clearing in futures, options, cash and OTC markets. Its exchanges list benchmark products tied to interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals, with trading conducted through CME Globex, fixed income markets through BrokerTec, foreign exchange through EBS and central counterparty services through CME Clearing.
Company news commonly covers quarterly results, clearing and transaction fee revenue, market data revenue, dividends, new futures and options contracts, benchmark administration and regulatory approvals affecting clearing or margin services. Recurring updates also include cryptocurrency and equity index product expansion, U.S. repo and Term SOFR reference-rate activity, and the Purdue University/CME Group Ag Economy Barometer.
CME Group announced the launch of the first-ever 30-Year Uniform Mortgage-Backed Securities (UMBS) TBA futures contracts on October 3, 2022, pending regulatory approval. This move aims to enhance liquidity and provide a capital-efficient risk management tool for mortgage-backed securities market participants. The UMBS TBA market has seen a daily trading volume of $195 billion recently, constituting 80% of the overall TBA volumes. The contracts will facilitate price discovery and risk transfer, backed by Fannie Mae and Freddie Mac, and will be listed on CME Globex.
CME Group will announce its Q2 2022 earnings on July 27, 2022, before market open. Written highlights will be posted on its website at 6:00 a.m. CT. Following the announcement, the company will host a conference call at 7:30 a.m. CT, allowing analysts to ask questions. A live audio Webcast will be available on their Investor Relations page, with an archived recording afterward. As the leading derivatives marketplace, CME Group provides extensive trading options across various asset classes.
The Purdue University/CME Group Ag Economy Barometer fell to 99 in May, marking its lowest level since April 2020, driven by rising production costs and uncertain input prices. The Index of Current Conditions dropped 26 points to 94, while the Index of Future Expectations dropped 21 points to 101. Producer concerns are escalating, with 38% anticipating worse financial performance in 2022. The Farm Capital Investment Index fell to an all-time low as 78% deemed it a bad time for large investments. Despite concerns, farmland value expectations remain optimistic.
CME Group announced that Terry Duffy, Chairman and CEO, will present at the Piper Sandler Global Exchange and FinTech Conference on June 9, 2022, at 10:30 a.m. (Eastern Time). This presentation will be livestreamed on CME Group's investor website, investor.cmegroup.com, where an audio replay will also be available 24 hours after the event. CME Group is a leading derivatives marketplace offering a range of products across major asset classes including interest rates, equity indexes, and foreign exchange.
CME Group reported record performance in May 2022, achieving the highest-ever average daily volume (ADV) of 24.3 million contracts, an 18% increase year-over-year. The Equity Index ADV saw a remarkable 49% growth, mainly due to record Micro E-mini S&P 500 futures volumes. Additionally, SOFR options and futures reached all-time highs in ADV and open interest (OI). Key figures include Interest Rate ADV of 11.6 million contracts and foreign exchange ADV rising by 25%. Overall, the international market also thrived, with ADV outside the U.S. increasing by 17%.
CME Group and the Mathematical Sciences Research Institute announced Nancy Stokey as the recipient of the 2021 CME Group-MSRI Innovative Quantitative Applications Prize. Recognizing her significant contributions to economics and mathematics, Stokey's work focuses on economic growth and technology's role in middle-income countries. Previous awardees include Nobel laureates. CME's Chairman expressed admiration for Stokey's impact on global economic discussions, emphasizing the prize coincides with the 50th Anniversary of the International Monetary Market.
CME Group Chairman and CEO Terry Duffy will testify on May 12, 2022, before the House Agriculture Committee regarding an FTX proposal that may increase systemic risks in the U.S. financial system. Duffy criticized FTX's proposal as inadequate, claiming it could eliminate up to $170 billion of loss-absorbing capital, weaken credit checks, and compromise risk management. The hearing will be held at 10:00 a.m. Eastern time, both online and in-person in Washington, D.C., with Duffy's testimony available on the CME Group website.
CME Group (NASDAQ: CME) released preliminary results from its 2022 annual meeting of shareholders held on May 4, 2022. Key outcomes include the election of 15 directors for a one-year term, the ratification of Ernst & Young LLP as the independent auditor, and the approval of several amended stock plans. However, the advisory vote on executive compensation was not approved. Class B-2 shareholders elected two directors, while no quorum was present for Class B-1 and B-3 director elections, leading to holdover directors. Official results will be filed with the SEC.
CME Group declared a second-quarter dividend of $1.00 per share, payable on June 27, 2022, to shareholders of record as of June 10, 2022. As the leading derivatives marketplace, CME Group enables clients to trade across various asset classes, optimizing portfolios and managing risk effectively. This dividend declaration underscores the company's commitment to returning value to shareholders.
The Purdue University/CME Group Ag Economy Barometer rose 8 points in April to 121, still 32% below last year's level. The Index of Current Conditions and Index of Future Expectations increased to 120 and 122, respectively, primarily driven by rising corn and soybean prices. Despite this, 42% of producers cited higher input costs as their main concern, with 60% expecting a 30% increase in input prices over the next year. Supply chain disruptions also hindered input availability, causing 34% of respondents to face difficulties in purchasing essential supplies.